These findings complement earlier studies which found overexpression of KLK4 was associated with an epithelial-to-mesenchymal transition in prostate cancer cells [8] and that KLK4 may modulate interactions between tumour cells and osteoblasts in the development of bone metastases [15]. This evidence concerns the gene KLK4 and prostate carcinoma.